品牌:NIBSC
起订:1ml
供应:100ml
发货:7天内
信息标签:NIBSC代理2,供应,化工,化学试剂
英国国家生物制品检定所(National Institute for Biological Standards and Control,NIBSC)是WHO的一个国际标准品供应中心实验室,它的核心工作是制备、保存和分发WHO用于检测全球生物制品质量的标准品。NIBSC制备的流感毒株和检测抗原、抗血清标准品,保障了各厂家顺利的研究和生产。NIBSC提供对投入英国市场的生物药品的独立测试,尤其是用于英国儿童免疫计划的疫苗;它同时也是欧盟控制药品进入欧盟市场的**药品控制实验室(OMCL)。 如果出现不能满足药品存放要求或患者出现不良反应等问题,NIBSC 也可对已投入欧盟市场的产品进行检验。
提供标准用于确保生物产品潜能的复杂化验要求使用生物学活性标准(有一批物质被指定了活性单位并用作“基准”)。 **卫生组织 (WHO) 国际标准系统提供了一组常用标准,它使得**各地的质量测试结果具有可比性,也因此而重要非凡。国际标准是“金标准”,各国以及各生产商都可据此制定出自己的生物学测试标准。
NIBSC 是目前**上 WHO 国际标准和参考材料的主要制作人和分发人(提供 95% 以上的标准)。对疫苗、治疗中的大多数生物技术产品以及其它许多生物产品的有效使用都取决于 NIBSC 所提供的国际生物学标准的可用性。
深圳远扬生物技术有限公司专业提供英国国家生物制品检定所(NIBSC)标准物质,原厂订货,质量保证,到货迅速,欢迎新老客户来电咨询。
08/100 Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1)
08/108 Influenza Virus Infectious NIBRG-91
08/114-004 Human Adenovirus serotype 2 for Nucleic Acid Amplification Techniques
08/118-004 Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques
08/120-004 Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques
08/126 Influenza anti A/turkey/Turkey/1/05(N1) NA Serum (NIBRG-74) (Sheep SH485)
08/138 Influenza Virus Infectious B/Florida/4/2006
08/140 Influenza Antigen B/Florida/4/2006
08/142 Influenza anti A/Anhui/1/05 (H5) HA serum (IBCDC-RG6) (sheep SH477)
08/148 Positive control for Luminex based anti-HLA Class II serology
08/150 HIV-2 RNA(1st International Standard)
08/154 Influenza Virus Infectious NIBRG-12
08/156 Influenza Virus Infectious NIBRG-23 30060 VE3
08/158 Fragile X Syndrome gDNA (1st International Genetic Reference Panel)
08/160 Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel)
08/174-006 Human Coxsackie B4 for Nucleic Acid Amplification Techniques
08/176-004 Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques
08/178-004 Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques
08/180-004 Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques
08/184 Influenza Antigen B/Malaysia/2506/2004
08/202 Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1)
08/204 Thyroid Stimulating Antibody (2nd I.S.)
08/208 Influenza Antigen Hong Kong/1073/99 (H9N2)
08/210 Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86)
08/214 Neisseria meningitidis serogroup C polysaccharide (1st International Standard)
08/216 Influenza Antigen A/Cambodia/R0405050/2007 (H5N1) NIBRG-88
08/218 Tetanus Toxoid Adsorbed (4th International Standard)
08/224-004 Human Herpes Simplex virus type 1 for Nucleic Acid Amplification Techniques
08/226-005 Human Herpes Simplex virus type 2 for Nucleic Acid Amplification Techniques
08/228 Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91
08/230 Streptodornase
08/246 Influenza anti A/Brisbane/10/2007- like HA serum
08/256 C1- Inhibitor, Concentrate (1st International Standard)
08/258 Antithrombin, Plasma (3rd International Standard)
08/262 C1 Inhibitor (Plasma)(1st International Standard)
08/266 Sex Hormone Binding Globulin.(2nd International Standard)
08/268 Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107
08/270 Anti-A and Anti-B in IVIG: Positive and Negative control panel(1st International Reference Reagent) (2 ampoules of 07/306 and 2 ampoules of 07/308)
08/278 Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C))
08/282 Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard)
08/298 Influenza Virus Infectious B/Brisbane/33/2008 30720 E5
08/300 Influenza Virus Infectious IVR-148
08/304 Influenza virus infectious NYMC X-175C
08/310-005 Varicella Zoster Virus(Type B) Working Reagent for Nucleic Acid Amplification Testing (NAT)
08/314-006 Human Cytomegalovirus for Nucleic Acid Amplification Techniques (AD169)
08/316-005 Epstein-Barr Virus for Nucleic Acid Amplification Techniques
08/318-005 Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing
08/320-004 Human metapneumovirus Working Reagent for Nucleic Acid Amplification Testing
08/324-004 Human Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing
08/356 Influenza anti A/Japan/305/57 (H2) HA serum (A/Singapore/1/57-Like) (Sheep SH398)
08/362 Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109
08/B531-14 QCRVZVQC1-Anti VZV:Quality Control Serum: Sample 1
08/B534-07 QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3
09/100 Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503)
09/110 Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard)
09/112 Negative Control for use in flow cytometry cross matching (FCXM) and anti-HLA serology
09/130 Influenza Virus Infectious NIBRG-122
09/132-003 Human Coronavirus 229E Working Reagent for Nucleic Acid Amplification Testing
09/136 Granulocyte colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard)
09/138 Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.)
09/140 Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel)
09/148 Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505)
09/154 Clostridium Sordellii anti-serum(1st International standard)
09/162 Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard)
09/170 Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody
09/172 Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard)
09/174 Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A) (Cell Derived)
09/182 VWF Factor Concentrate (2nd International Standard)
09/184 Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14
09/186 Anti-Chagas Disease (TcII) Ig in Human Plasma(1st International Standard)
09/188 Anti-Chagas Disease (TcI) Ig in Human Plasma (1st International Standard)
09/196 Influenza Antigen A/California/7/2009 (H1N1v) (NIBRG-121xp) (Egg Derived)
09/234 Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-ß 3) (1st International Standard)
09/236 Influenza Virus Infectious IVR-153
09/242 Fibrinogen Concentrate (B)(2nd International Standard)
09/260 Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard)
09/264 Fibrinogen Plasma (D)(3rd International Standard)
09/266 Glial cell line-derived neurotrophic factor, GDNF
09/268 Influenza Virus Infectious NIBRG-121xp
09/272 Placental Growth Factor
09/274 Influenza Virus Infectious NYMC X-185
09/276 Influenza Virus Infectious A/Brisbane/59/2007
09/280 Influenza Virus Infectious NIB-64
09/284 Anti-Human Neutrophil Antibody 1a WHO Reference Reagent
09/304 Influenza Virus Infectious IVR-155
09/306 Influenza Virus Infectious NIBRG-147
09/308 Influenza serology antigen reagent for haemagglutination inhibition assay Pandemic H1N1 2009 (X179A)
09/310 Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183)
09/316 Influenza Anti B Neuraminidase Serum (B/Florida/4/2006)
09/B558-04 QCRHIV1RTDQC1- Anti-HIV1 Quality Control Serum: Sample 1 for Rapid Test Devices
09/B577-06 QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample1
09/B584-10 QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1
09/B588-05 QCRTOXOQC1-Anti-Toxoplasma Quality Control Serum: Sample 1
10/104 Reteplase
10/120 Influenza Antiserum A/Brisbane/59/2007 (H1N1)(IVR-148) HA (sheep 516 and 517)
10/128 Diphtheria Polyclonal Antibody
10/130 Diphtheria Monoclonal Antibody
10/132 Tetanus Polyclonal Antibody
10/134 Tetanus Monoclonal Antibody
10/136-001 HLA-DRB1 Genotyping Reference Panel
10/140 Anti-human papillomavirus[HPV] 18 (1st International Standard)
10/142 Negative control for Luminex based anti-HLA serology
10/150-006 Anti Hepatitis C Virus
10/152 HIV-1 RNA (3rd International standard)
10/154-004 Anti-HCV (1 in 8 dilution)(British Working Standard)
10/176 Interleukin-29 (Interferon Lamda 1)
10/178 Endotoxin (3rd International Standard)
10/188 Factor VIII Concentrate (13th British Standard).
10/202 Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard)
10/214 Influenza Anti A/Hong Kong 1073/99 (N2)NA Serum (Sheep SH395 SH396)
10/218 Influenza Anti A/California/7/2009 (N1) NA Serum (Sheep SH 521)
10/226 Influenza Virus Infectious IVR-158
10/232 Genomic DNA for blood group genotyping RBC1(AR1R1)(International Reference Reagent)
10/234 Genomic DNA for blood group genotyping RBC12 (ODpsi)(International Reference Reagent)
10/236 Genomic DNA for blood group genotyping RBC4(OR1R2)(International Reference Reagent)
10/238 Genomic DNA for blood group genotyping RBC5(Brr)(International Reference Reagent)
10/252 Factor VII Concentrate(2nd International Standard)
10/258 Influenza Antigen A/California/7/2009-like(NIB-74)
10/262 Diphtheria Antitoxin Human IgG(1st International Standard)
10/264 Hepatitis B Virus for Nucleic Acid Amplification Techniques (3rd WHO International Standard)
10/272 BCG vaccine of Moreau-RJ sub-strain(1st International Reference Reagent)
10/276 Influenza virus infectious BX-31
10/276 Influenza virus infectious BX-31
10/280 Anti-HLA Control
10/286 Follicle Stimulating Hormone, Leutinizing Hormone human, urinary for bioassay(5th International Standard)
10/B592-07 QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1
10/B594-05 QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1
10/B596-07 QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1
10/B596-08 QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1
10/B599-05 QCRCMVQC1- Anti CMV: Quality Control Serum: Sample 1
1050 Anti-Poliovirus monoclonal antibodies No: 1050 Type 2
11/106 Influenza Virus infectious A/Perth/16/2009
11/106 Influenza Virus infectious A/Perth/16/2009
11/108 Influenza Virus infectious NYMC X-187
11/108 Influenza Virus infectious NYMC X-187
11/126 Factors II and X Concentrate (4th International standard)
11/130 Influenza Virus Infectious NIBRG-14
11/130 Influenza Virus Infectious NIBRG-14
11/134 Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived)
11/170 Erythropoietin, recombinant, for Bioassay (3rd International Standard)
11/176 Low Molecular Weight Heparin 2 (3rd International Standard)
11/182-001 HBV DNA Working Reagent
11/184 High Molecular Weight Urokinase(2nd International Standard)
11/206 Influenza anti-A/Perth/16/2009 HA Serum
11/208-001 Parvovirus B19 DNA
11/210 Anti-human CD4 FITC conjugated 0.5ml
11/214 Blood Group Genotyping Reference Panel ((International Reference Reagent)
11/216 Chagas Antibody Reference Panel ( 1st International Standard)
11/218-001 MLH1/MSH2 Exon Copy Number Reference Panel
11/222 Influenza Virus Infectious NIB-79
11/226 Influenza Virus Infectious A/Victoria/361/2011
11/232 Influenza Virus Infectious B/Texas/6/2011
11/234 Immunoglobulin E(IgE) human serum (3rd International Standard)
11/236 Factor XIa (1st International Reference Reagent)
11/244 Influenza Virus Infectiious NYMC BX-49
11/B601-04 QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1
11/B603-04 QCRHIV2QC2-Anti HIV2:Quality Control Serum: Sample2
11/B603-05 QCRHIV2QC2-Anti HIV2:Quality Control Serum: Sample2
11/B604-001 QCRFLUAH5QC1 Influenza H5 PC1
11/B606-03 QCRNEGQC1-Negative Quality Control Serum: Sample1
11/B608-01 QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1
12/100 Influenza Virus Infectious NYMC X-217
12/104 Poliovirus Vaccine Inactivated (3rd International Standard)
12/106 Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39)
12/110 Influenza Antigen B/Wisconsin/1/2010 (cell derived)
12/112 Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187)
12/114 Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165)
12/116 Influenza anti-A/Victoria/361/2011-like HA serum
12/118 Influenza anti-B/Wisconsin/1/2010-like HA serum
12/122 Influenza virus infectious A/turkey/Italy/3889/1999
12/154 Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard)
12/168 Influenza Antigen A/California/7/09 (H1N1) (NYMCX-181) Egg derived
12/172 3rd HCV RNA Genotype Panel for Nucleic acid amplification techniques
12/174 Infectious Virus Influenza A/California/7/2009
12/176 Methylated Human Serum Albumin (mHSA)
12/188 Pegylated Granulocyte colony Stimulating Factor (Human, rDNA derived)
12/196-001 Hereditary Haemochromatosis Genotyping Reference Panel
12/198 Influenza virus infectious B/Wisconsin/1/2010 34490 E5
12/200 Influenza virus infectious B/Brisbane/60/2008 34500 E7
12/202 Influenza virus infectious NYMC BX-39
12/204 Influenza Virus infectious IVR-165
12/208 Parvovirus B19 (3rd International Standard)
12/224 HIV-1 NAT subtypes (Main)(2nd International Reference Preparation)
12/248-001 JAK2 V617F Genotyping Sensitivity Panel
12/282 Diphtheria Toxin 1Lf/ml
12/284 Anti-meningococcal serogroup Y monoclonal antibody
12/288 Influenza Virus Infectious B/Massachusetts/2/2012
12/290 Influenza Virus Infectious B/Brisbane/36/2012
12/294 Influenza Virus Infectious NYMC BX-51C
12/298 Influenza Virus Infectious A/Texas/50/2012
12/302 Diphtheria Antitoxin Equine DI (International Standard)
12/B611-01 Anti-VZV Quality control serum: Sample 1 QCRVZV IgM QC1
12/B612-02 QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1
12/B613-02 QCRRUBQC2-Anti-Rubella: Quality Control Serum: Sample 2
12/B614-04 QCRHBsQC1- Anti HBs Quality Control Serum: Sample 1
12/B620-02 QCRHIV1P24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2
12/B620-03 QCRHIV1P24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2
12/B622-04 QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1
12/B623-001 QCRFLUAH1N1QC1-Influenza AH1N1 QC1
13/102-001 Hepatitis A Virus RNA Working Reagent
13/106 Influenza Antigen B/Massachusetts/02/2012
13/108 Anti-Meningococcal serogroup B monoclonal antibody
13/112 Influenza Antigen A/Texas/50/2012 (NYMC X-223)
13/116 Influenza Antigen A/Texas/50/2012 (NYMC X-223A)
13/126 Influenza anti-B/Brisbane/60/2008-like HA serum
13/134 Influenza Antigen B/Massachusetts/02/2012 (Egg derived)
13/152 Influenza Antigen B/Massachusetts/02/2012 (cell derived)
13/162 Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived)
13/164 Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A)
13/166 Influenza anti-A/Anhui/1/2013 (N9) NA Serum
13/168-001 Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques
13/176 Influenza Virus Infectious NIBRG-88
13/178 Influenza Anti-A/Texas/50/2012-like HA Serum
13/180 Influenza A/Anhui/1/2013 (H7) HA Serum
13/182 Influenza Anti-B/Massachusetts/02/2012-like HA Serum
13/198 Influenza Virus Infectious NYMC X-181
13/200 Influenza Virus Infectious NIB-74
13/202 Influenza Virus Infectious NIB-74xp
13/214 HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel)
13/216 Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal
13/224 Influenza virus Infectious NIB-85. 36210 E5
13/228 Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4
13/234 Influenza Antigen B/Brisbane/60/2008
13/248 Influenza virus infectious NIBRG-267
13/250 Influenza Virus Infectious NIBRG-268
13/252 Influenza virus infectious NYMC X-223A
13/254 Influenza Anti-B/Brisbane/60/2008 HA Serum (sheep 570,574,599 and 600)
13/256 Influenza virus infectious. NYMC x-233
13/258 Influenza virus infectious NYMC X-233A
13/264 Influenza Virus Infectious NYMC X-223
13/B625-03 QCRHBsGQC2-HBsAg Quality Control Serum: Sample2
13/B627-02 QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1
13/B629-03 QCRHBeQC1-Anti-HBe Quality Control Serum: sample1
13/B631-02 QCRHBsGQC1-HBsAg Quality Control Serum: Sample1
13/B634-02 QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2
13/B636-02 QCRHIV1QC2- Anti-HIV 1: Quality Control Serum: Sample 2
13/B638-02 QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample2
13/B642-02 QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1
13/B644-01 QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3
14/106 Influenza virus infectious. NYMC BX-51B
14/116 Influenza virus infectious NYMC X-179A
14/118 Influenza virus infectious B/Massachusetts/2/2012
14/134 Influenza Anti-A/California/7/2009 HA Serum
14/144 Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011) (sheep SH598)
14/154 Influenza virus infectious. NYMC BX-35
14/184 Influenza Virus Infectious NIB-88
14/204 Influenza Virus Infectious B/Brisbane/9/2014
14/206 Influenza virus infectious NYMC X-247
14/224 Influenza virus infectious. A/Switzerland/9715293/2013
14/226 Influenza Virus Infectious A/South Australia/55/2014
14/228 Influenza Virus Infectious A/Stockholm/6/2014
14/230 Influenza Virus Infectious. A/Norway/466/2014
14/232 Influenza Virus Infectious IVR-175
14/234 Influenza protein calibration standard
14/236 Influenza Virus Infectious B/Phuket/3073/2013 39960 E6
14/248 Influenza Anti-B/Phuket/3073/2013-HA Serum (Sheep 614,615,616,617)